Actively Recruiting

Phase Not Applicable
Age: 65Years - 80Years
All Genders
NCT06499038

The Ace Avanteon Study - A Randomized Controled Trial

Led by Helse Møre og Romsdal HF · Updated on 2024-08-28

60

Participants Needed

1

Research Sites

218 weeks

Total Duration

On this page

Sponsors

H

Helse Møre og Romsdal HF

Lead Sponsor

S

St. Olavs Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this randomized controled trial is to compare if using of ancillary screws yields equal results as no use of ancillary screws in the ACE acetabulum cup of a total hip arthroplasty. Further, the migration of the Avanteon stem over time will be assessed. Patients included are patients with hip osteoarthritis from 65-80 years old. The purpose of this study is to compare implant migration and early fixation of a hybrid hip replacement combining the uncemented ACE acetabular component and the cemented Avanteon femoral stem, by using CT based Radiostereometric Analysis, a new innovative method for evaluating implant migration. Our study may predict the long term survival of the implants used. Participants will go through total hip arthroplasty, and be followed by CT-RSA, plain x-rays and patients reported outcome measures.

CONDITIONS

Official Title

The Ace Avanteon Study - A Randomized Controled Trial

Who Can Participate

Age: 65Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with primary hip osteoarthritis between the age of 65 and 80 years at time of surgery
  • Patients requiring primary total hip replacement
  • Patients who understand the study and can follow scheduled clinical and radiographic evaluations
Not Eligible

You will not qualify if you...

  • Patients unable to provide informed consent
  • Patients requiring revision hip arthroplasty
  • Patients who have had previous osteotomy or osteosynthesis of femur or acetabulum
  • Patients with metabolic bone disease other than osteoporosis
  • Patients with inflammatory arthritis
  • Patients with severe obesity affecting daily activities (BMI > 40)
  • Patients with active or suspected infection
  • Patients with malignancy
  • Patients unable to cooperate due to language or psychosocial conditions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kristiansund Hospital, Møre and Romsdal Hospital Trust

Kristiansund, Møre and Romsdal, Norway, 6508

Actively Recruiting

Loading map...

Research Team

M

Myrthle Hoel, Nurse

CONTACT

M

Mathias Brevik, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here